EGFR and neoplasm: In the second-line setting, amplification of the wt EGFR allele in addition to the presence of the EGFR-ex19del allele constituted a novel mechanism of resistance.45–47 A study by Kim and colleagues48 also revealed increased EGF mRNA expression in tumour tissue samples of patients who progressed on osimertinib.